嗜水气单胞菌对新型抗生素的体外敏感性
In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.
作者信息
Fainstein V, Weaver S, Bodey G P
出版信息
Antimicrob Agents Chemother. 1982 Sep;22(3):513-4. doi: 10.1128/AAC.22.3.513.
Abstract
The antibiotic susceptibilities of 16 clinical isolates of Aeromonas hydrophila obtained from cancer patients with septicemia were studied. Of the new beta-lactam antibiotics tested, azthreonam and moxalactam were the most active, followed by cefoperazone, cefotaxime, and ceftizoxime. Excellent activity was demonstrated by chloroamphenicol, tetracycline, aminoglycosides, and trimethoprim-sulfamethoxazole. Semisynthetic penicillins had no appreciable activity against this organism.
摘要
对从患有败血症的癌症患者中分离出的16株嗜水气单胞菌临床菌株的抗生素敏感性进行了研究。在所测试的新型β-内酰胺类抗生素中，氨曲南和拉氧头孢最具活性，其次是头孢哌酮、头孢噻肟和头孢唑肟。氯霉素、四环素、氨基糖苷类和甲氧苄啶-磺胺甲恶唑表现出优异的活性。半合成青霉素对该菌没有明显活性。
相似文献
1
In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.
Antimicrob Agents Chemother. 1982 Sep;22(3):513-4. doi: 10.1128/AAC.22.3.513.
2
In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.
Antimicrob Agents Chemother. 1985 Jul;28(1):151-3. doi: 10.1128/AAC.28.1.151.
3
In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.
Antimicrob Agents Chemother. 1981 Feb;19(2):357-8. doi: 10.1128/AAC.19.2.357.
4
Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.
Antimicrob Agents Chemother. 1996 May;40(5):1260-2. doi: 10.1128/AAC.40.5.1260.
5
In vitro susceptibility of Aeromonas caviae, Aeromonas hydrophila and Aeromonas sobria to fifteen antibacterial agents.
Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):413-7. doi: 10.1007/BF01979472.
6
Antimicrobial susceptibility of sixty human fecal isolates of Aeromonas species.
Eur J Clin Microbiol Infect Dis. 1989 Mar;8(3):248-50. doi: 10.1007/BF01965270.
7
Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.
Antimicrob Agents Chemother. 1985 Apr;27(4):643-5. doi: 10.1128/AAC.27.4.643.
8
Antibiotic sensitivities of Aeromonas hydrophila cultured from medicinal leeches.
Br J Plast Surg. 1988 Nov;41(6):649-51. doi: 10.1016/0007-1226(88)90176-2.
9
Susceptibilities of motile Aeromonas sp. to antimicrobial agents.
Zentralbl Bakteriol. 1991 Apr;275(1):85-93. doi: 10.1016/s0934-8840(11)80771-1.
10
Sensitivities of Aeromonas hydrophila cultured from medicinal leeches to oral antibiotics.
J Reconstr Microsurg. 1990 Apr;6(2):135-7. doi: 10.1055/s-2007-1006813.
引用本文的文献
1
Seasonal incidence of and antibiotic resistance among Aeromonas species isolated from domestic wastewater before and after treatment in stabilization ponds.
Microb Ecol. 1992 May;23(3):227-37. doi: 10.1007/BF00164098.
2
Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.
J Clin Microbiol. 1999 Mar;37(3):706-8. doi: 10.1128/JCM.37.3.706-708.1999.
3
Differential susceptibility of aeromonads and coliforms to cefsulodin.
Appl Environ Microbiol. 1996 Jun;62(6):1885-8. doi: 10.1128/aem.62.6.1885-1888.1996.
4
Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.
Antimicrob Agents Chemother. 1996 May;40(5):1260-2. doi: 10.1128/AAC.40.5.1260.
5
In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.
Antimicrob Agents Chemother. 1993 Apr;37(4):905-7. doi: 10.1128/AAC.37.4.905.
6
Aeromonas hydrophilia tenosynovitis in an immunocompromised host.
Indian J Pediatr. 1984 Sep-Oct;51(412):609-10. doi: 10.1007/BF02776632.
7
Isolation of enterotoxigenic, hemolytic, and antibiotic-resistant Aeromonas hydrophila strains from infected fish in Bangladesh.
Appl Environ Microbiol. 1984 Oct;48(4):865-7. doi: 10.1128/aem.48.4.865-867.1984.
8
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1984 Nov;28(5):375-425. doi: 10.2165/00003495-198428050-00002.
9
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.
10
Growth of Aeromonas spp. on cefsulodin-Irgasan-novobiocin agar selective for Yersinia enterocolitica.
J Clin Microbiol. 1985 Oct;22(4):478-80. doi: 10.1128/jcm.22.4.478-480.1985.
本文引用的文献
1
In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.
Antimicrob Agents Chemother. 1981 Feb;19(2):357-8. doi: 10.1128/AAC.19.2.357.
2
Aeromonas hydrophila bacteremia in ambulatory immunocompromised hosts.
Am J Med. 1980 Feb;68(2):238-42. doi: 10.1016/0002-9343(80)90360-5.
3
Comparative in vitro study of SQ26,776.
Antimicrob Agents Chemother. 1982 Feb;21(2):294-8. doi: 10.1128/AAC.21.2.294.
4
Antimicrobial susceptibility of Aeromonas hydrophila.
Antimicrob Agents Chemother. 1980 Apr;17(4):612-4. doi: 10.1128/AAC.17.4.612.
5
In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.
Antimicrob Agents Chemother. 1980 Sep;18(3):483-6. doi: 10.1128/AAC.18.3.483.
6
Human aeromonas infections: a review of the literature and a case report of endocarditis.
Medicine (Baltimore). 1978 May;57(3):267-77.
Zotero 插件